 |
市場調査レポート
商品コード
1441273
生物活性材料の世界市場規模、シェア、成長分析、タイプ別、用途別-産業予測、2023～2030年Global Bioactive Materials Market Size, Share, Growth Analysis, By Type(Natural Biomaterial, Metallic Biomaterial), By Application(Neurology, Cardiology) - Industry Forecast 2023-2030 |
||||||
| 生物活性材料の世界市場規模、シェア、成長分析、タイプ別、用途別-産業予測、2023～2030年 |
|
出版日: 2024年02月17日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
生物活性材料の世界市場規模は、2022年に22億6,000万米ドルと評価され、2023年の25億5,000万米ドルから2031年には67億9,000万米ドルに成長し、予測期間（2024～2031年）のCAGRは13％で成長する展望です。
同市場は、高度なインプラント材料に対する需要の高まりと、従来の金属製インプラントに対する不安の高まりにより、パラダイムシフトが促され、大きな成長の兆しを見せています。生体活性材料は、体液や組織との強固な結合能力で知られ、組織の治癒や修復のために医療や医療領域でますます求められるようになっているほか、抗菌製品、医薬品、化粧品の製造にも利用され、市場の拡大に拍車をかけています。細胞移植、修復、再生、再建に特化していることから、さまざまな整形外科手術や生物工学的な取り組みに広く採用されていることが、市場を前進させる上で極めて重要です。耐摩耗性、細菌侵入、耐湿性に優れているにもかかわらず、高度な加工ツールや技術に多額の初期投資が必要なため、市場の拡大は抑制される可能性があります。
目次
エグゼクティブサマリー
- 市場概要
- 繁栄と衰退
調査手法
- 情報調達
- セカンダリとプライマリデータソース
- 市場規模の推定
- 市場の前提条件と制限
親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要市場の考察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料の分析
- イノベーションマトリクス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資の分析
- 主要成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制情勢
- ポーターの分析
- 将来の混乱についての特別な考察
生物活性材料の世界市場：タイプ別
- 市場概要
- 天然生体材料
- 金属生体材料
- セラミック生体材料
- ポリマー生体材料
生物活性材料の世界市場：用途別
- 市場概要
- 神経内科
- 心臓病学
- 整形外科
- 眼科
- 創傷ケア
- 歯科
- 形成外科
- その他
生物活性材料の世界市場規模：地域別
- 市場概要
- 北米
- 米国
- カナダ
- 欧州
- ドイツ
- スペイン
- フランス
- 英国
- その他の欧州地域
- アジア太平洋
- 中国
- インド
- 日本
- 韓国
- その他のアジア太平洋
- ラテンアメリカ
- ブラジル
- その他のラテンアメリカ地域
- 中東・アフリカ
- GCC諸国
- 南アフリカ
- その他中東・アフリカ地域
競合情勢
- 上位5社の比較
- 主要企業の市場ポジショニング（2021年）
- 主要市場企業が採用した戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア（2021年）
主要企業プロファイル
- Medtronic plc（アイルランド）
- Evonik Industries AG（ドイツ）
- Carpenter Technology Corporation（米国）
- Berkeley Advanced Biomaterials（米国）
- Invibio Ltd（英国）
- Zimmer Biomet Holdings, Inc.（米国）
- BASF SE（ドイツ）
- Covalon Technologies Ltd（カナダ）
- Stryker（米国）
- Johnson & Johnson（米国）
- Dentsply Sirona（米国）
- CoorsTek Inc.（米国）
- Corbion（オランダ）
- Royal DSM NV（オランダ）
- 3M Company（米国）
- Amedica Corporation（米国）
- Ceramtec GmbH（ドイツ）
- Cam Bioceramics（韓国）
- Alphatec Spine, Inc.（米国）
- Wright Medical Group, Inc.（米国）
Global Bioactive Materials Market size was valued at USD 2.26 billion in 2022 and is poised to grow from USD 2.55 billion in 2023 to USD 6.79 billion by 2031, growing at a CAGR of 13% during the forecast period (2024-2031).
The market is on the cusp of significant growth driven by escalating demand for advanced implantable materials and growing apprehensions about traditional metal implants, prompting a paradigm shift. Bioactive materials, renowned for their robust bonding capabilities with fluids and tissues, are increasingly sought after in medical and healthcare domains for tissue healing and repair, as well as in the production of antibacterial products, pharmaceuticals, and cosmetics, thereby fueling market expansion. Their widespread adoption in various orthopedic surgeries and bioengineering endeavors is pivotal in advancing the market, given their specialization in cellular transplants, repair, regeneration, and reconstruction. Despite their resilience to wear, bacterial infiltration, and moisture, the market's expansion might be tempered by the significant initial investment required for sophisticated processing tools and technology.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Bioactive Materials Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Bioactive Materials Market Segmental Analysis
The global bioactive materials market is segmented on the basis of type, application, region. By type, the market is segmented into powder, moldable, granules, and others. By application, the market is segmented into dentistry, surgery, bioengineering, others. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.
Drivers of the Global Bioactive Materials Market
One of the primary factors driving the Global Bioactive Materials Market is the rising demand within the healthcare sector, particularly for orthopedic surgeries and tissue engineering applications. The increasing focus on advanced implantable materials that demonstrate strong bonding capabilities with fluids and tissues has led to bioactive materials becoming favored by both medical practitioners and researchers. Their effectiveness in tissue healing, repair, and regeneration, along with their potential for producing antibacterial products, pharmaceuticals, and cosmetics, further solidifies their market demand. With healthcare technologies advancing and concerns regarding traditional metal implants remaining, bioactive materials are poised to experience continuous growth in the foreseeable future.
Restraints in the Global Bioactive Materials Market
A major impediment facing the Global Bioactive Materials Market is the significant expenses tied to research and development (R&D). The creation of bioactive materials requires thorough research, experimentation, and validation procedures to guarantee their effectiveness, safety, and adherence to regulatory requirements, necessitating substantial investments in advanced laboratories, specialized equipment, expert staff, and clinical trials. Moreover, the ongoing demand for innovation and enhancement to maintain competitiveness exacerbates R&D spending. Consequently, the substantial R&D costs present a substantial obstacle for smaller enterprises and startups seeking entry into the market, potentially constraining overall market growth despite its optimistic outlook.
Market Trends of the Global Bioactive Materials Market
An emerging trend in the global bioactive materials market is the integration of nanotechnology, which involves manipulating materials at the nanoscale to enhance their properties and performance. Nanotechnology offers the potential to revolutionize bioactive materials by enabling precise control over their structure and functionality, leading to improvements in biocompatibility, durability, and therapeutic efficacy. Through the incorporation of nanoparticles and nanostructures, bioactive materials can achieve enhanced drug delivery, tissue regeneration, and antimicrobial properties, opening up new opportunities for applications in medical implants, drug delivery systems, and tissue engineering. As research and development in nanotechnology continue to advance, the integration of nanomaterials is expected to drive innovation and competitiveness within the global bioactive materials market, further propelling its growth and expansion.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Bioactive Materials Market by Type
- Market Overview
- Natural Biomaterial
- Metallic Biomaterial
- Ceramic Biomaterial
- and Polymeric Biomaterial
Global Bioactive Materials Market by Application
- Market Overview
- Neurology
- Cardiology
- Orthopedics
- Ophthalmology
- Wound Care
- Dental
- Plastic Surgery
- and Other Applications
Global Bioactive Materials Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Medtronic plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Evonik Industries AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Carpenter Technology Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Berkeley Advanced Biomaterials (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Invibio Ltd (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet Holdings, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BASF SE (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Covalon Technologies Ltd (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Stryker (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dentsply Sirona (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CoorsTek Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Corbion (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Royal DSM NV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- 3M Company (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amedica Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Ceramtec GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cam Bioceramics (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alphatec Spine, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wright Medical Group, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
